NBD AI Bulletin -- Jinyu Bio-Technology CO.,LTD on January 21 released a performance forecast, saying that the Company's net profit attributable to shareholders in 2020 is expected to be 400 million yuan to 435 million yuan, which is 179 million yuan ~214 million yuan more from last year, up 80.96%~96.80% year over year.

The 2019 annual report shows that the main business of Jinyu Bio-Technology is biopharmaceutical, other business, accounting for 95.6%,3.77% of revenue, respectively.

Jinyu Bio-Technology's chairman is Zhang Chongyu, male, 67 years old, master's degree, senior economist. The president of Jinyu Bio-Technology is Zhang Jing, female, 38 years old, master's degree.

(By Gao Han)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.